Your session is about to expire
← Back to Search
CAM2029 for Polycystic Liver Disease (POSITANO Trial)
POSITANO Trial Summary
This trial is testing a new treatment for PLD, which is a condition that can cause problems with the liver. The new treatment is being compared to a placebo, and participants will be randomly assigned to one of three groups. The trial will last for 53 weeks, and participants may then choose to continue treatment for an additional 24 weeks.
POSITANO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPOSITANO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From undefined Phase 2 trial • 4 Patients • NCT00005906POSITANO Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have cysts outside my liver that may make it unsafe for me to join the trial.I have experienced symptoms like bloating or abdominal pain recently.I have been treated with a somatostatin analogue within the last 3 months.I have severe liver disease (Child-Pugh class C).I am 18 years old or older.I am not planning to have surgery for liver cysts during the trial.I have been diagnosed with PLD, with a specific volume measurement.I had surgery for PLD less than 3 months ago.My kidney function is severely impaired.My previous treatment with PLD and SSA did not work.I have had gallstones or gallstone-related issues due to SSAs, treated by surgery.
- Group 1: CAM2029 once every 2 weeks
- Group 2: CAM2029 once weekly
- Group 3: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you share how many people are currently signed up for the research project?
"Yes, you are correct. The listing on clinicaltrials.gov currently says that the research team is still recruiting patients for the study. The original posting date was June 28th, 2022 and the most recent update was on September 21st, 2022. 69 individuals are needed for the trial, which will take place at 2 different locations."
Does this clinical trial have any available openings for new participants?
"Indeed, the information available on clinicaltrials.gov supports that this trial is still recruiting patients. This study was first advertised on June 28th, 2022 and was updated as recently as September 21st, 2022. Currently, they are looking for 69 individuals across 2 sites."
Share this study with friends
Copy Link
Messenger